Correlation Between Morgan Stanley and Response Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Response Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Response Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley and Response Oncology, you can compare the effects of market volatilities on Morgan Stanley and Response Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Response Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Response Oncology.

Diversification Opportunities for Morgan Stanley and Response Oncology

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Morgan and Response is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley and Response Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Response Oncology and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley are associated (or correlated) with Response Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Response Oncology has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Response Oncology go up and down completely randomly.

Pair Corralation between Morgan Stanley and Response Oncology

If you would invest (100.00) in Response Oncology on September 20, 2024 and sell it today you would earn a total of  100.00  from holding Response Oncology or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Morgan Stanley  vs.  Response Oncology

 Performance 
       Timeline  
Morgan Stanley 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Morgan Stanley unveiled solid returns over the last few months and may actually be approaching a breakup point.
Response Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Response Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Response Oncology is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Morgan Stanley and Response Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morgan Stanley and Response Oncology

The main advantage of trading using opposite Morgan Stanley and Response Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Response Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Response Oncology will offset losses from the drop in Response Oncology's long position.
The idea behind Morgan Stanley and Response Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years